• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2型糖尿病和非酒精性脂肪性肝病患者循环骨形态发生蛋白-9水平降低。

Circulating Bone Morphogenetic Protein-9 is Decreased in Patients with Type 2 Diabetes and Non-Alcoholic Fatty Liver Disease.

作者信息

Hao Jianan, Wang Yichao, Huo Lijing, Sun Tiantian, Zhen Yunfeng, Gao Zhe, Chen Shuchun, Ren Luping

机构信息

Endocrinology Department, Hebei General Hospital, Shijiazhuang, Hebei, 050000, People's Republic of China.

Graduate School of Hebei Medical University, Shijiazhuang, Hebei, 050000, People's Republic of China.

出版信息

Int J Gen Med. 2022 Dec 7;15:8539-8546. doi: 10.2147/IJGM.S385513. eCollection 2022.

DOI:10.2147/IJGM.S385513
PMID:36514745
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9741848/
Abstract

OBJECTIVE

We aimed to examine the association between bone morphogenetic protein-9 (BMP-9) and type 2 diabetes mellitus (T2DM) in conjunction with non-alcoholic fatty liver disease (NAFLD) and insulin resistance (IR) and to identify evidence supporting the potential role of BMP-9 in the clinical prevention and treatment of T2DM in conjunction with NAFLD.

METHODS

One hundred and twenty subjects were included in this study. We sorted all of the subjects into four groups of equal size (n=30 each). A trained expert assessed the height, weight, systolic blood pressure (SBP), and diastolic blood pressure (DBP) of the subjects and computed the body mass index (BMI). All subjects had their fasting blood glucose (FBG), fasting insulin (FINS), serum BMP-9, and biochemical indices assessed.

RESULTS

Significant variations were observed in BMI, SBP, DBP, ALT, TC, TG, HDL-C, LDL-C, ApoB, FBG, FINS, HOMA-IR, and serum BMP-9 among the four groups (P<0.05). The level of serum BMP-9 was positively correlated with HDL-C, while the level of serum BMP-9 was negatively correlated with BMI, SBP, DBP, ALT, TC, TG, LDL-C, FBG, FINS, and HOMA-IR. Multiple stepwise regression analyses revealed that FINS, LDL-C, HDL-C, and BMI were independent factors impacting serum BMP-9 levels (P<0.05). Logistic regression analyses revealed that BMP-9 was a protective factor for T2DM paired with NAFLD, while HOMA-IR was a risk factor.

CONCLUSION

Serum BMP-9 levels are significantly lower in the T2DM+NAFLD group when compared to other groups, and BMP-9 is an independent risk factor for T2DM paired with NAFLD.

摘要

目的

我们旨在研究骨形态发生蛋白-9(BMP-9)与2型糖尿病(T2DM)、非酒精性脂肪性肝病(NAFLD)及胰岛素抵抗(IR)之间的关联,并确定支持BMP-9在T2DM合并NAFLD临床防治中潜在作用的证据。

方法

本研究纳入120名受试者。我们将所有受试者平均分为四组(每组n = 30)。一名经过培训的专家对受试者的身高、体重、收缩压(SBP)和舒张压(DBP)进行评估,并计算体重指数(BMI)。所有受试者均接受空腹血糖(FBG)、空腹胰岛素(FINS)、血清BMP-9及生化指标检测。

结果

四组受试者的BMI、SBP、DBP、谷丙转氨酶(ALT)、总胆固醇(TC)、甘油三酯(TG)、高密度脂蛋白胆固醇(HDL-C)、低密度脂蛋白胆固醇(LDL-C)、载脂蛋白B(ApoB)、FBG、FINS、稳态模型评估的胰岛素抵抗指数(HOMA-IR)及血清BMP-9存在显著差异(P < 0.05)。血清BMP-9水平与HDL-C呈正相关,而与BMI、SBP、DBP、ALT、TC、TG、LDL-C、FBG、FINS及HOMA-IR呈负相关。多元逐步回归分析显示,FINS、LDL-C、HDL-C及BMI是影响血清BMP-9水平的独立因素(P < 0.05)。逻辑回归分析显示,BMP-9是T2DM合并NAFLD的保护因素,而HOMA-IR是危险因素。

结论

与其他组相比,T2DM + NAFLD组血清BMP-9水平显著降低,且BMP-9是T2DM合并NAFLD的独立危险因素。

相似文献

1
Circulating Bone Morphogenetic Protein-9 is Decreased in Patients with Type 2 Diabetes and Non-Alcoholic Fatty Liver Disease.2型糖尿病和非酒精性脂肪性肝病患者循环骨形态发生蛋白-9水平降低。
Int J Gen Med. 2022 Dec 7;15:8539-8546. doi: 10.2147/IJGM.S385513. eCollection 2022.
2
Correlation of blood glucose, serum chemerin and insulin resistance with NAFLD in patients with type 2 diabetes mellitus.2型糖尿病患者血糖、血清趋化素与胰岛素抵抗和非酒精性脂肪性肝病的相关性
Exp Ther Med. 2018 Mar;15(3):2936-2940. doi: 10.3892/etm.2018.5753. Epub 2018 Jan 16.
3
Serum Ferritin level, microalbuminuria and non-alcoholic fatty liver disease in type 2 diabetic patients.2型糖尿病患者的血清铁蛋白水平、微量白蛋白尿与非酒精性脂肪性肝病
Diabetes Metab Syndr. 2019 May-Jun;13(3):2226-2229. doi: 10.1016/j.dsx.2019.05.030. Epub 2019 May 25.
4
[Effects of resolving method of Chinese medicine on the lipid metabolism in polycystic ovary syndrome accompanied with non-alcoholic fatty liver disease].[中药化解法对多囊卵巢综合征伴非酒精性脂肪性肝病脂质代谢的影响]
Zhongguo Zhong Xi Yi Jie He Za Zhi. 2013 Jun;33(6):751-6.
5
The Risk Factor Analysis for Type 2 Diabetes Mellitus Patients with Nonalcoholic Fatty Liver Disease and Positive Correlation with Serum Uric Acid.2型糖尿病合并非酒精性脂肪性肝病患者的危险因素分析及与血清尿酸的正相关性
Cell Biochem Biophys. 2015 Jul;72(3):643-7. doi: 10.1007/s12013-014-0346-1.
6
Serum retinol binding protein 4 is negatively related to beta cell function in Chinese women with non-alcoholic fatty liver disease: a cross-sectional study.血清视黄醇结合蛋白 4 与中国非酒精性脂肪性肝病女性患者的胰岛β细胞功能呈负相关:一项横断面研究。
Lipids Health Dis. 2013 Oct 27;12:157. doi: 10.1186/1476-511X-12-157.
7
Serum phospholipid omega-3 polyunsaturated fatty acids and insulin resistance in type 2 diabetes mellitus and non-alcoholic fatty liver disease.2型糖尿病和非酒精性脂肪性肝病患者血清磷脂ω-3多不饱和脂肪酸与胰岛素抵抗
J Diabetes Complications. 2014 Sep-Oct;28(5):711-4. doi: 10.1016/j.jdiacomp.2014.04.008. Epub 2014 Apr 18.
8
The value of neck circumference (NC) as a predictor of non-alcoholic fatty liver disease (NAFLD).颈围(NC)作为非酒精性脂肪性肝病(NAFLD)预测指标的价值。
J Clin Transl Endocrinol. 2014 Jul 23;1(4):133-139. doi: 10.1016/j.jcte.2014.07.001. eCollection 2014 Dec.
9
Associations Between Thyroid Hormones Within the Euthyroid Range and Indices of Obesity in Obese Chinese Women of Reproductive Age.甲状腺激素在正常范围内与肥胖中国育龄妇女肥胖指数之间的关联。
Metab Syndr Relat Disord. 2019 Oct;17(8):416-422. doi: 10.1089/met.2019.0036. Epub 2019 Jul 29.
10
Expression of C1q/TNF-related protein-3 (CTRP3) in serum of patients with gestational diabetes mellitus and its relationship with insulin resistance.妊娠期糖尿病患者血清中 C1q/TNF 相关蛋白-3(CTRP3)的表达及其与胰岛素抵抗的关系。
Eur Rev Med Pharmacol Sci. 2017 Dec;21(24):5702-5710. doi: 10.26355/eurrev_201712_14016.

引用本文的文献

1
Development of a 5-Year Risk Prediction Model for Transition From Prediabetes to Diabetes Using Machine Learning: Retrospective Cohort Study.使用机器学习开发一个用于预测糖尿病前期转变为糖尿病的5年风险预测模型:回顾性队列研究。
J Med Internet Res. 2025 May 9;27:e73190. doi: 10.2196/73190.
2
Therapeutic potential of 4-hexylresorcinol in reducing sarcopenia in diabetic masseter muscle.4-己基间苯二酚在减轻糖尿病咬肌肌肉减少症方面的治疗潜力。
Maxillofac Plast Reconstr Surg. 2025 Jan 20;47(1):2. doi: 10.1186/s40902-025-00457-w.
3
ALK1 Signaling in Human Cardiac Progenitor Cells Promotes a Pro-angiogenic Secretome.人类心脏祖细胞中的ALK1信号传导促进促血管生成分泌组。
J Cell Signal. 2024;5(3):122-142. doi: 10.33696/signaling.5.119.
4
Unveiling the Impact of BMP9 in Liver Diseases: Insights into Pathogenesis and Therapeutic Potential.揭示 BMP9 在肝脏疾病中的作用:发病机制和治疗潜力的深入了解。
Biomolecules. 2024 Aug 15;14(8):1013. doi: 10.3390/biom14081013.
5
Circulating Bone morphogenetic protein 9 (BMP9) as a new biomarker for noninvasive stratification of nonalcoholic fatty liver disease and metabolic syndrome.循环骨形态发生蛋白 9(BMP9)作为非酒精性脂肪性肝病和代谢综合征无创分层的新生物标志物。
Clin Exp Med. 2024 Mar 16;24(1):55. doi: 10.1007/s10238-024-01316-0.
6
Circulating bone morphogenetic protein 8A is a novel biomarker to predict advanced liver fibrosis.循环骨形态发生蛋白8A是预测晚期肝纤维化的一种新型生物标志物。
Biomark Res. 2023 Apr 27;11(1):46. doi: 10.1186/s40364-023-00489-2.

本文引用的文献

1
CRISPR-mediated BMP9 ablation promotes liver steatosis via the down-regulation of PPARα expression.CRISPR 介导的 BMP9 基因敲除通过下调 PPARα 的表达促进肝脏脂肪变性。
Sci Adv. 2020 Nov 27;6(48). doi: 10.1126/sciadv.abc5022. Print 2020 Nov.
2
The global epidemiology of NAFLD and NASH in patients with type 2 diabetes: A systematic review and meta-analysis.全球 2 型糖尿病患者非酒精性脂肪性肝病和非酒精性脂肪性肝炎的流行病学:系统评价和荟萃分析。
J Hepatol. 2019 Oct;71(4):793-801. doi: 10.1016/j.jhep.2019.06.021. Epub 2019 Jul 4.
3
Role of bone morphogenetic protein-9 in the regulation of glucose and lipid metabolism.骨形态发生蛋白-9 在调节糖和脂代谢中的作用。
FASEB J. 2019 Sep;33(9):10077-10088. doi: 10.1096/fj.201802544RR. Epub 2019 Jun 25.
4
Non-alcoholic fatty liver disease: causes, diagnosis, cardiometabolic consequences, and treatment strategies.非酒精性脂肪性肝病:病因、诊断、心血管代谢后果和治疗策略。
Lancet Diabetes Endocrinol. 2019 Apr;7(4):313-324. doi: 10.1016/S2213-8587(18)30154-2. Epub 2018 Aug 30.
5
Elevated leptin and decreased adiponectin independently predict the post-thrombotic syndrome in obese and non-obese patients.肥胖和非肥胖患者中,瘦素升高和脂联素降低均可独立预测血栓后综合征。
Sci Rep. 2018 May 2;8(1):6938. doi: 10.1038/s41598-018-25135-y.
6
Circulating bone morphogenetic protein-9 in relation to metabolic syndrome and insulin resistance.循环骨形态发生蛋白-9 与代谢综合征和胰岛素抵抗的关系。
Sci Rep. 2017 Dec 13;7(1):17529. doi: 10.1038/s41598-017-17807-y.
7
BMP-9 interferes with liver regeneration and promotes liver fibrosis.BMP-9 会干扰肝脏再生并促进肝纤维化。
Gut. 2017 May;66(5):939-954. doi: 10.1136/gutjnl-2016-313314. Epub 2017 Mar 23.
8
Nonalcoholic fatty liver disease is associated with an increased prevalence of distal symmetric polyneuropathy in adult patients with type 1 diabetes.非酒精性脂肪性肝病与1型糖尿病成年患者远端对称性多发性神经病的患病率增加有关。
J Diabetes Complications. 2017 Jun;31(6):1021-1026. doi: 10.1016/j.jdiacomp.2017.01.024. Epub 2017 Feb 12.
9
Decreased circulating BMP-9 levels in patients with Type 2 diabetes is a signature of insulin resistance.2 型糖尿病患者循环 BMP-9 水平降低是胰岛素抵抗的特征。
Clin Sci (Lond). 2017 Feb 1;131(3):239-246. doi: 10.1042/CS20160543. Epub 2016 Dec 9.
10
BMP-9 enhances fibroblast growth factor 21 expression and suppresses obesity.骨形态发生蛋白-9增强成纤维细胞生长因子21的表达并抑制肥胖。
Biochim Biophys Acta. 2016 Jul;1862(7):1237-46. doi: 10.1016/j.bbadis.2016.04.006. Epub 2016 Apr 13.